Operaciones Amphastar P - AMPH CFD
Agregar a Favoritos- Resumen
- Datos históricos
- Eventos
- Cuenta de resultados
- Balance de situación
- Flujo de caja
- Propiedad
Condiciones de trading
| Diferencial | 0.10 | ||||||||
|
Tarifa nocturna posición alcista
Long position overnight fee
Ir a la plataforma | -0.025457% | ||||||||
|
Tarifa nocturna posición bajista
Short position overnight fee
Ir a la plataforma | 0.003235% | ||||||||
| Horario tarifa nocturna | 21:00 (UTC) | ||||||||
| Cantidad comercializada mínima | 1 | ||||||||
| Divisa | USD | ||||||||
| Margen | 20% | ||||||||
| Mercado de valores | United States of America | ||||||||
| Comisión por operación | 0% |
*Information provided by Capital.com
Amphastar Pharmaceuticals Inc ESG Risk Ratings
High Medium Low Negligible
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Estadísticas clave
| Cierre previo* | 33.2 |
| Abrir* | 32.44 |
| Cambio de 1 año* | -4.98% |
| Rango del día* | 32.44 - 34.38 |
| Rango de 52 semanas | 26.76-45.50 |
| Volumen medio (10 días) | 408.77K |
| Volumen medio (3 meses) | 8.50M |
| Capitalización de mercado | 2.13B |
| Ratio P/E | 24.75 |
| Acciones en circulación | 48.27M |
| Ingresos | 518.64M |
| EPS | 1.78 |
| Dividendo (Rendimiento %) | N/A |
| Beta | 0.77 |
| Próxima fecha de resultados | Aug 7, 2023 |
"Todos los datos son proporcionados por Refinitiv, excepto los datos marcados con un asterisco, que son *datos proporcionados por Capital.com"
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Cierre | Change | Change (%) | Apertura | High | Low |
|---|---|---|---|---|---|---|
| Jun 29, 2022 | 34.11 | 0.74 | 2.22% | 33.37 | 34.44 | 32.19 |
| Jun 28, 2022 | 33.20 | -0.76 | -2.24% | 33.96 | 34.31 | 32.82 |
| Jun 27, 2022 | 34.22 | 2.48 | 7.81% | 31.74 | 34.62 | 31.74 |
| Jun 24, 2022 | 31.72 | -1.13 | -3.44% | 32.85 | 32.85 | 31.47 |
| Jun 23, 2022 | 32.67 | 0.99 | 3.13% | 31.68 | 32.84 | 31.67 |
| Jun 22, 2022 | 31.67 | 0.41 | 1.31% | 31.26 | 32.32 | 31.26 |
| Jun 21, 2022 | 31.55 | 0.09 | 0.29% | 31.46 | 32.44 | 31.11 |
| Jun 17, 2022 | 31.48 | 0.26 | 0.83% | 31.22 | 32.45 | 31.22 |
| Jun 16, 2022 | 31.05 | 0.13 | 0.42% | 30.92 | 31.33 | 30.49 |
| Jun 15, 2022 | 31.30 | 0.32 | 1.03% | 30.98 | 31.78 | 30.30 |
| Jun 14, 2022 | 30.98 | 1.24 | 4.17% | 29.74 | 31.15 | 29.74 |
| Jun 13, 2022 | 29.71 | 0.84 | 2.91% | 28.87 | 30.49 | 28.87 |
| Jun 10, 2022 | 29.97 | 0.30 | 1.01% | 29.67 | 30.80 | 29.26 |
| Jun 9, 2022 | 30.12 | -7.39 | -19.70% | 37.51 | 38.57 | 28.59 |
| Jun 8, 2022 | 38.21 | -3.26 | -7.86% | 41.47 | 42.20 | 37.41 |
| Jun 7, 2022 | 41.31 | 4.00 | 10.72% | 37.31 | 41.83 | 37.31 |
| Jun 6, 2022 | 37.43 | -0.53 | -1.40% | 37.96 | 38.22 | 37.23 |
| Jun 3, 2022 | 37.67 | -0.19 | -0.50% | 37.86 | 38.68 | 36.56 |
| Jun 2, 2022 | 38.17 | 1.20 | 3.25% | 36.97 | 38.36 | 36.28 |
| Jun 1, 2022 | 37.59 | 0.48 | 1.29% | 37.11 | 38.04 | 36.05 |
Amphastar P Events
| Hora (UTC) (UTC) | País | Evento |
|---|---|---|
| Monday, June 5, 2023 | ||
| Hora (UTC) (UTC) 18:00 | País US
| Evento Amphastar Pharmaceuticals Inc Annual Shareholders Meeting Amphastar Pharmaceuticals Inc Annual Shareholders MeetingForecast -Previous - |
| Monday, August 7, 2023 | ||
| Hora (UTC) (UTC) 20:00 | País US
| Evento Q2 2023 Amphastar Pharmaceuticals Inc Earnings Release Q2 2023 Amphastar Pharmaceuticals Inc Earnings ReleaseForecast -Previous - |
| Monday, November 6, 2023 | ||
| Hora (UTC) (UTC) 21:00 | País US
| Evento Q3 2023 Amphastar Pharmaceuticals Inc Earnings Release Q3 2023 Amphastar Pharmaceuticals Inc Earnings ReleaseForecast -Previous - |
- Anual
- Trimestral
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Ingresos totales | 498.987 | 437.768 | 349.846 | 322.357 | 294.666 |
| Ingresos | 498.987 | 437.768 | 349.846 | 322.357 | 294.666 |
| Coste de los ingresos, total | 250.127 | 238.029 | 206.506 | 190.434 | 187.681 |
| Beneficio bruto | 248.86 | 199.739 | 143.34 | 131.923 | 106.985 |
| Gastos totales de explotación | 396.89 | 354.281 | 338.892 | 322.396 | 303.289 |
| Gastos de venta/general/administración Gastos, total | 66.592 | 68.92 | 65.157 | 63.109 | 58.044 |
| Investigación y desarrollo | 64.71 | 49.924 | 57.11 | 60.262 | 52.433 |
| Ingresos de explotación | 102.097 | 83.487 | 10.954 | -0.039 | -8.623 |
| Ingresos por intereses (gastos), netos No operativos | -0.525 | -0.284 | 0.268 | 0.878 | 0.213 |
| Otros, netos | 14.468 | 0.936 | -6.585 | 59.389 | -1.516 |
| Ingresos netos antes de impuestos | 116.04 | 84.139 | 4.637 | 60.228 | -9.926 |
| Ingresos netos después de impuestos | 92.563 | 63.509 | 1.097 | 46.505 | -6.66 |
| Intereses menores | 0 | -1.185 | 0.306 | 2.434 | 0.922 |
| Beneficio neto antes de partidas extra. Elementos | 91.386 | 62.116 | 1.403 | 48.939 | -5.738 |
| Ingresos netos | 91.386 | 62.116 | 1.403 | 48.939 | -5.738 |
| Ingresos disponibles para los accionistas, excluyendo las partidas extra. Elementos | 91.386 | 62.116 | 1.403 | 48.939 | -5.738 |
| Ingresos disponibles para los accionistas, incluidos los elementos extra. Elementos | 91.386 | 62.116 | 1.403 | 48.939 | -5.738 |
| Beneficio neto diluido | 91.386 | 62.116 | 1.403 | 48.939 | -5.738 |
| Promedio ponderado de acciones diluidas | 52.427 | 49.784 | 49.124 | 49.907 | 46.395 |
| BPA diluido sin partidas extraordinarias | 1.74311 | 1.24771 | 0.02856 | 0.9806 | -0.12368 |
| BPA normalizado diluido | 1.82527 | 1.04151 | -0.14081 | 0.05385 | -0.12368 |
| Depreciation / Amortization | 10.061 | 11.008 | 10.119 | 8.591 | 5.131 |
| Gastos (ingresos) extraordinarios | 5.4 | -13.6 | 0 | ||
| Equity In Affiliates | -1.177 | -0.208 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Ingresos totales | 140.022 | 135.023 | 120.129 | 123.467 | 120.368 |
| Ingresos | 140.022 | 135.023 | 120.129 | 123.467 | 120.368 |
| Coste de los ingresos, total | 66.182 | 63.855 | 61.619 | 60.111 | 64.542 |
| Beneficio bruto | 73.84 | 71.168 | 58.51 | 63.356 | 55.826 |
| Gastos totales de explotación | 111.989 | 97.191 | 96.901 | 98.644 | 104.154 |
| Gastos de venta/general/administración Gastos, total | 20.592 | 16.1 | 16.768 | 15.735 | 17.989 |
| Investigación y desarrollo | 17.373 | 14.822 | 16.041 | 20.25 | 13.597 |
| Depreciation / Amortization | 2.442 | 2.414 | 2.473 | 2.548 | 2.626 |
| Gastos (ingresos) extraordinarios | 5.4 | 0 | 0 | 0 | 5.4 |
| Ingresos de explotación | 28.033 | 37.832 | 23.228 | 24.823 | 16.214 |
| Ingresos por intereses (gastos), netos No operativos | 0.526 | 0.052 | -0.235 | -0.168 | -0.174 |
| Otros, netos | 5.01 | 3.376 | -0.397 | -1.504 | 12.993 |
| Ingresos netos antes de impuestos | 33.569 | 41.26 | 22.596 | 23.151 | 29.033 |
| Ingresos netos después de impuestos | 26.817 | 33.97 | 16.037 | 17.6 | 24.956 |
| Intereses menores | 0 | 0 | 0 | 0 | |
| Beneficio neto antes de partidas extra. Elementos | 26.032 | 33.913 | 15.874 | 17.346 | 24.253 |
| Ingresos netos | 26.032 | 33.913 | 15.874 | 17.346 | 24.253 |
| Ingresos disponibles para los accionistas, excluyendo las partidas extra. Elementos | 26.032 | 33.913 | 15.874 | 17.346 | 24.253 |
| Ingresos disponibles para los accionistas, incluidos los elementos extra. Elementos | 26.032 | 33.913 | 15.874 | 17.346 | 24.253 |
| Beneficio neto diluido | 26.032 | 33.913 | 15.874 | 17.346 | 24.253 |
| Promedio ponderado de acciones diluidas | 51.97 | 51.713 | 52.788 | 53.227 | 51.979 |
| BPA diluido sin partidas extraordinarias | 0.5009 | 0.65579 | 0.30071 | 0.32589 | 0.46659 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| BPA normalizado diluido | 0.58391 | 0.65579 | 0.30071 | 0.32589 | 0.55589 |
| Equity In Affiliates | -0.785 | -0.057 | -0.163 | -0.254 | -0.703 |
- Anual
- Trimestral
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Total Activo Corriente | 378.319 | 318.119 | 279.682 | 255.241 | 220.342 |
| Efectivo e inversiones a corto plazo | 175.762 | 136.673 | 105.619 | 85.36 | 89.168 |
| Efectivo y Equivalentes | 156.098 | 126.353 | 92.642 | 73.685 | 86.337 |
| Inversiones a corto plazo | 19.664 | 10.32 | 12.977 | 11.675 | 2.831 |
| Total deudores, neto | 88.975 | 78.93 | 66.39 | 45.687 | 52.212 |
| Accounts Receivable - Trade, Net | 88.804 | 78.804 | 66.005 | 45.376 | 52.163 |
| Total Inventory | 103.584 | 92.807 | 96.831 | 110.501 | 69.322 |
| Prepaid Expenses | 7.563 | 7.274 | 6.777 | 9.538 | 5.485 |
| Other Current Assets, Total | 2.435 | 2.435 | 4.065 | 4.155 | 4.155 |
| Total Assets | 741.987 | 671.529 | 631.236 | 586.971 | 513.563 |
| Property/Plant/Equipment, Total - Net | 264.573 | 271.491 | 280.709 | 253.548 | 210.418 |
| Property/Plant/Equipment, Total - Gross | 484.603 | 471.11 | 464.856 | 417.953 | 359.51 |
| Accumulated Depreciation, Total | -220.03 | -199.619 | -184.147 | -164.405 | -149.092 |
| Goodwill, Net | 3.126 | 3.313 | 3.94 | 3.634 | 3.951 |
| Intangibles, Net | 34.172 | 35.557 | 36.675 | 37.519 | 38.316 |
| Other Long Term Assets, Total | 59.383 | 39.064 | 30.23 | 37.029 | 40.536 |
| Total Current Liabilities | 94.862 | 103.81 | 112.201 | 90.009 | 106.834 |
| Accounts Payable | 20.501 | 22.214 | 24.357 | 25.061 | 31.323 |
| Accrued Expenses | 66.744 | 70.313 | 74.504 | 55.165 | 56.095 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 3.046 | 2.202 | 12.263 | 7.741 | 18.229 |
| Other Current Liabilities, Total | 4.571 | 9.081 | 1.077 | 2.042 | 1.187 |
| Total Liabilities | 213.329 | 226.007 | 228.93 | 205.605 | 181.128 |
| Total Long Term Debt | 72.839 | 74.776 | 34.186 | 39.394 | 31.984 |
| Long Term Debt | 72.839 | 74.776 | 34.186 | 39.394 | 31.984 |
| Deferred Income Tax | 0.144 | 0.534 | 0.741 | 0.867 | 1.031 |
| Other Liabilities, Total | 45.484 | 46.887 | 35.385 | 29.173 | 9.355 |
| Total Equity | 528.658 | 445.522 | 402.306 | 381.366 | 332.435 |
| Common Stock | 0.006 | 0.006 | 0.005 | 0.005 | 0.005 |
| Additional Paid-In Capital | 455.077 | 422.423 | 410.061 | 367.305 | 344.434 |
| Retained Earnings (Accumulated Deficit) | 271.723 | 180.337 | 117.773 | 116.37 | 67.485 |
| Treasury Stock - Common | -189.524 | -150.479 | -121.812 | -97.627 | -75.476 |
| Other Equity, Total | -8.624 | -6.765 | -3.721 | -4.687 | -4.013 |
| Total Liabilities & Shareholders’ Equity | 741.987 | 671.529 | 631.236 | 586.971 | 513.563 |
| Total Common Shares Outstanding | 48.1121 | 47.7149 | 47.4954 | 46.577 | 46.6311 |
| Minority Interest | 0 | 46.417 | 46.162 | 31.924 | |
| Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 2.414 | 3.985 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Total Activo Corriente | 407.67 | 378.319 | 384.222 | 377.145 | 364.415 |
| Efectivo e inversiones a corto plazo | 192.892 | 175.762 | 184.087 | 183.391 | 187.01 |
| Efectivo y Equivalentes | 176.615 | 156.098 | 157.244 | 166.157 | 172.627 |
| Inversiones a corto plazo | 16.277 | 19.664 | 26.843 | 17.234 | 14.383 |
| Total deudores, neto | 101.369 | 88.975 | 88.464 | 86.688 | 73.389 |
| Accounts Receivable - Trade, Net | 100.638 | 88.804 | 77.099 | 80.81 | 73.166 |
| Total Inventory | 103.647 | 103.584 | 103.25 | 98.733 | 95.147 |
| Prepaid Expenses | 7.327 | 7.563 | 5.986 | 5.898 | 6.434 |
| Other Current Assets, Total | 2.435 | 2.435 | 2.435 | 2.435 | 2.435 |
| Total Assets | 773.656 | 741.987 | 726.695 | 723.719 | 716.238 |
| Property/Plant/Equipment, Total - Net | 269.986 | 264.573 | 259.798 | 264.727 | 271.369 |
| Property/Plant/Equipment, Total - Gross | 496.57 | 484.603 | 472.993 | 472.76 | 474.624 |
| Accumulated Depreciation, Total | -226.584 | -220.03 | -213.195 | -208.033 | -203.255 |
| Goodwill, Net | 3.175 | 3.126 | 2.886 | 3.054 | 3.256 |
| Intangibles, Net | 34.004 | 34.172 | 34.151 | 34.646 | 35.18 |
| Other Long Term Assets, Total | 57.063 | 59.383 | 42.948 | 41.082 | 38.7 |
| Total Current Liabilities | 105.635 | 94.862 | 102.19 | 103.634 | 114.364 |
| Accounts Payable | 21.979 | 20.501 | 19.963 | 31.071 | 23.843 |
| Accrued Expenses | 69.898 | 66.744 | 79.016 | 69.909 | 75.246 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 2.168 | 3.046 | 1.68 | 2.057 | 2.159 |
| Other Current Liabilities, Total | 11.59 | 4.571 | 1.531 | 0.597 | 13.116 |
| Total Liabilities | 225.079 | 213.329 | 221.53 | 224.412 | 236.713 |
| Total Long Term Debt | 72.872 | 72.839 | 74.011 | 73.871 | 74.348 |
| Long Term Debt | 72.872 | 72.839 | 74.011 | 73.871 | 74.348 |
| Deferred Income Tax | 0.178 | 0.144 | 0.242 | 0.364 | 0.487 |
| Minority Interest | |||||
| Other Liabilities, Total | 46.394 | 45.484 | 45.087 | 46.543 | 47.514 |
| Total Equity | 548.577 | 528.658 | 505.165 | 499.307 | 479.525 |
| Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 |
| Common Stock | 0.006 | 0.006 | 0.006 | 0.006 | 0.006 |
| Additional Paid-In Capital | 456.623 | 455.077 | 448.741 | 443.042 | 433.454 |
| Retained Earnings (Accumulated Deficit) | 297.755 | 271.723 | 237.81 | 221.936 | 204.59 |
| Treasury Stock - Common | -197.539 | -189.524 | -171.461 | -156.968 | -151.28 |
| Other Equity, Total | -8.268 | -8.624 | -9.931 | -8.709 | -7.245 |
| Total Liabilities & Shareholders’ Equity | 773.656 | 741.987 | 726.695 | 723.719 | 716.238 |
| Total Common Shares Outstanding | 48.1792 | 48.1121 | 48.6125 | 48.9923 | 48.7522 |
| Long Term Investments | 1.758 | 2.414 | 2.69 | 3.065 | 3.318 |
- Anual
- Trimestral
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Ingresos netos/Línea de salida | 91.386 | 63.301 | 1.097 | 46.505 | -6.66 |
| Efectivo de actividades de explotación | 89.181 | 97.994 | 57.266 | 41.762 | 38.191 |
| Efectivo de actividades de explotación | 23.815 | 22.196 | 20.491 | 17.073 | 14.529 |
| Amortization | 1.42 | 1.29 | 1.036 | 1.037 | 1.987 |
| Deferred Taxes | -16.445 | 2.388 | -0.162 | 4.542 | -1.414 |
| Partidas no monetarias | 21.182 | 10.743 | 25.676 | 24.352 | 17.645 |
| Cash Taxes Paid | 44.442 | 8.096 | 3.411 | 5.717 | 0.339 |
| Intereses pagados en efectivo | 3.023 | 2.109 | 2.199 | 2.435 | 2.376 |
| Cambios en el capital circulante | -32.177 | -1.924 | 9.128 | -51.747 | 12.104 |
| Efectivo de actividades de inversión | -32.777 | -28.672 | -36.415 | -50.527 | -42.182 |
| Gastos de capital | -24.034 | -27.456 | -33.855 | -41.555 | -46.808 |
| Otras partidas de flujo de caja de inversión, total | -8.743 | -1.216 | -2.56 | -8.972 | 4.626 |
| Efectivo procedente de actividades de financiación | -26.439 | -37.018 | -2.246 | -3.783 | 25.008 |
| Elementos de flujo de caja de financiación | -0.407 | -56.169 | -0.106 | ||
| Emisión (retiro) de acciones, neto | -24.251 | -12.948 | -1.26 | -0.572 | 21.935 |
| Emisión (amortización) de deuda, neta | -1.781 | 32.099 | -0.88 | -3.211 | 3.073 |
| Efectos del cambio de divisas | -0.22 | -0.223 | 0.352 | -0.104 | -0.274 |
| Variación neta de la tesorería | 29.745 | 32.081 | 18.957 | -12.652 | 20.743 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | 26.032 | 91.386 | 57.473 | 41.599 | 24.253 |
| Cash From Operating Activities | 40.382 | 89.181 | 73.955 | 53.58 | 50.765 |
| Cash From Operating Activities | 6.252 | 23.815 | 17.615 | 11.411 | 5.615 |
| Amortization | 0.241 | 1.42 | 1.088 | 0.696 | 0.352 |
| Non-Cash Items | 7.996 | 21.182 | 16.104 | 7.964 | 3.541 |
| Cash Taxes Paid | 0.336 | 44.442 | 35.166 | 23.964 | 0.183 |
| Cash Interest Paid | 1.245 | 3.023 | 1.96 | 1.167 | 0.579 |
| Changes in Working Capital | -0.139 | -32.177 | -18.325 | -8.09 | 17.004 |
| Cash From Investing Activities | -6.333 | -32.777 | -32.548 | -17.29 | -9.11 |
| Capital Expenditures | -9.477 | -24.034 | -17.724 | -12.101 | -6.139 |
| Other Investing Cash Flow Items, Total | 3.144 | -8.743 | -14.824 | -5.189 | -2.971 |
| Cash From Financing Activities | -13.548 | -26.439 | -10.277 | 3.654 | 4.648 |
| Issuance (Retirement) of Stock, Net | -12.58 | -24.251 | -8.22 | 4.874 | 5.208 |
| Issuance (Retirement) of Debt, Net | -0.968 | -1.781 | -1.653 | -1.131 | -0.538 |
| Foreign Exchange Effects | 0.016 | -0.22 | -0.239 | -0.14 | -0.029 |
| Net Change in Cash | 20.517 | 29.745 | 30.891 | 39.804 | 46.274 |
| Deferred Taxes | -16.445 | ||||
| Financing Cash Flow Items | 0 | -0.407 | -0.404 | -0.089 | -0.022 |
| Nombre del Inversor | Tipo de inversor | Porcentaje pendiente | Acciones en propiedad | Cambio de acciones | Fechas de holding | Índice de rotación |
|---|---|---|---|---|---|---|
| Applied Physics & Chemistry Laboratories, Inc. | Corporation | 14.1436 | 6827679 | 0 | 2023-03-31 | LOW |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 12.0105 | 5797932 | -251276 | 2023-03-31 | LOW |
| Federated Hermes Global Investment Management Corp. | Investment Advisor/Hedge Fund | 6.5627 | 3168080 | -240 | 2023-03-31 | LOW |
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 5.4772 | 2644066 | 28912 | 2023-03-31 | LOW |
| Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 3.9723 | 1917571 | 51027 | 2023-03-31 | LOW |
| Zhang (Jack Yongfeng) | Individual Investor | 3.8966 | 1881046 | -4869 | 2023-03-31 | LOW |
| Luo (Mary Z) | Individual Investor | 2.8453 | 1373546 | -32125 | 2023-03-31 | LOW |
| State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 2.8162 | 1359495 | 985 | 2023-03-31 | LOW |
| Fuller & Thaler Asset Management Inc. | Investment Advisor/Hedge Fund | 1.6814 | 811694 | 311629 | 2023-03-31 | LOW |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.5743 | 759981 | 37700 | 2023-03-31 | LOW |
| Invesco Capital Management LLC | Investment Advisor | 1.1536 | 556877 | -57011 | 2023-03-31 | LOW |
| Granite Investment Partners, LLC | Investment Advisor | 1.112 | 536821 | 525027 | 2023-03-31 | MED |
| Renaissance Technologies LLC | Hedge Fund | 1.0291 | 496800 | 49400 | 2023-03-31 | HIGH |
| T. Rowe Price Associates, Inc. | Investment Advisor | 0.9551 | 461048 | -321442 | 2023-03-31 | LOW |
| Neuberger Berman, LLC | Investment Advisor/Hedge Fund | 0.8933 | 431252 | 431252 | 2023-03-31 | LOW |
| BlackRock Financial Management, Inc. | Investment Advisor/Hedge Fund | 0.826 | 398757 | -141503 | 2023-03-31 | LOW |
| Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.7527 | 363353 | 5978 | 2023-03-31 | LOW |
| Millennium Management LLC | Hedge Fund | 0.7117 | 343560 | 246130 | 2023-03-31 | HIGH |
| Portolan Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.7055 | 340593 | 69802 | 2023-03-31 | HIGH |
| Nordea Funds Oy | Investment Advisor | 0.684 | 330213 | -7214 | 2023-03-31 | LOW |
¿Por qué operar con Capital.com? Nuestros números hablan por nosotros
Capital.com Group530K+
Traders
87K+
Clientes activos mensualmente
$46M+
Volumen mensual de inversión
$31M+
Retiros por mes
Calculadora de trading
Calcula tus P&L hipotéticas en el supuesto de haber abierto una operación con CFD en una fecha determinada (selecciona una fecha) y haberla cerrado en otra fecha (selecciona una fecha).
Comisión de la operación
0
- 1:1
Apalancamiento
1:1
- 20
- 100
- 500
- 1000
- 10000
Inversión
Tamaño de la operación (Apalancamiento x Inversión)
Apertura
Cierre
En corto En largo
Amphastar P Company profile
Sobre Amphastar Pharmaceuticals Inc
Amphastar Pharmaceuticals, Inc. es una empresa biofarmacéutica. La empresa se centra principalmente en el desarrollo, la fabricación, la comercialización y la venta de productos genéricos e inyectables, de inhalación e intranasales, así como de productos de ingrediente farmacéutico activo de insulina, o API de insulina. Fabrica y vende más de 20 productos. Opera a través de dos segmentos: productos farmacéuticos acabados y productos API. Sus productos comercializados incluyen Primatene Mist, Enoxaparin, Glucagon for Injection Emergency Kit, Naloxone y otros productos farmacéuticos acabados. Primatene Mist, un producto de inhalación de epinefrina de venta libre, está indicado para el alivio temporal de los síntomas leves del asma intermitente. La enoxaparina es una forma inyectable de heparina de bajo peso molecular que se utiliza como anticoagulante, indicada para múltiples indicaciones, entre ellas la prevención y el tratamiento de la trombosis venosa profunda. El glucagón inyectable es un producto inyectable de difícil fabricación.
El precio actual de la acción Amphastar P en tiempo real es 34.14 USD. El gráfico de la acción permite a los inversores comprender mejor el rendimiento y el precio de la acción y tomar decisiones informadas al negociar acciones y CFD.
Descubra más acciones con gráficos, datos vitales y actualizaciones de precios en tiempo real: Veidekke, Paycom Software, Inc., Cadence Design Systems, Inc., SGX, ALD SA y OraSure. Para obtener más información, consulte los perfiles de las empresas en Capital.com.
| Industry: | Pharmaceuticals (NEC) |
11570 6th St
RANCHO CUCAMONGA
CALIFORNIA 91730
US
Cuenta de resultados
- Annual
- Quarterly
A la gente también le interesa
¿Aún estás buscando un bróker de confianza?
Únete a más de 530.000 traders de todo el mundo que eligen operar con Capital.com